NeuroAiD® (MLC601) and Amyloid Precursor Protein Processing

Publisher： Karger

E-ISSN： 1421-9786|35|1|30-37

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.35, Iss.1, 2013-03, pp. : 30-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of MLC601 (NeuroAiD®), a Traditional Chinese Medicine, in Poststroke Recovery: A Systematic Review

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-03 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study

By  

Cerebrovascular Diseases, Vol. 43, Iss. 1-2, 2016-11 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

The NeuroAiD II (MLC901) in Vascular Cognitive Impairment Study (NEURITES)

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-03 ,pp. : 23-29

Karger

Access to resources Recommend Favorite

NeuroAiD: Properties for Neuroprotection and Neurorepair

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-03 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

The pharmacology of amyloid precursor protein processing

By Racchi M.   Govoni S.  

Experimental Gerontology, Vol. 38, Iss. 1, 2003-01 ,pp. : 145-157

Elsevier

Access to resources Recommend Favorite